Production (Stage)
Tharimmune, Inc.
THAR
$1.36
-$0.0124-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.67M | 6.04M | 5.82M | 5.59M | 5.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.63M | 12.43M | 11.12M | 9.10M | 9.09M |
| Operating Income | -12.63M | -12.43M | -11.12M | -9.10M | -9.09M |
| Income Before Tax | -12.48M | -12.20M | -10.85M | -8.88M | -8.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.48 | -12.20 | -10.85 | -8.88 | -8.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.48M | -12.20M | -10.85M | -8.88M | -8.89M |
| EBIT | -12.63M | -12.43M | -11.12M | -9.10M | -9.09M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -8.00 | -9.56 | -18.11 | -55.08 | -104.72 |
| Normalized Basic EPS | -5.00 | -5.97 | -11.32 | -34.43 | -65.45 |
| EPS Diluted | -8.00 | -9.56 | -18.11 | -55.08 | -104.72 |
| Normalized Diluted EPS | -5.00 | -5.97 | -11.32 | -34.43 | -65.45 |
| Average Basic Shares Outstanding | 6.87M | 5.18M | 3.63M | 2.13M | 1.21M |
| Average Diluted Shares Outstanding | 6.87M | 5.18M | 3.63M | 2.13M | 1.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |